pirmagrel has been researched along with Coronary Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lefer, AM; Mentley, R; Sun, JZ | 1 |
| Lucchesi, BR; Rosenthal, G; Simpson, PJ; Smith, CB | 1 |
| Friehling, TD; Kelliher, GJ; Kowey, PR; MacNab, MW; O'Connor, KM; Wetstein, L | 1 |
3 other study(ies) available for pirmagrel and Coronary Disease
| Article | Year |
|---|---|
Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium.
Topics: Animals; Cats; Coronary Disease; Creatine Kinase; Drug Synergism; Hemodynamics; Imidazoles; Male; Myocardium; Necrosis; Pyridines; Thromboxane B2; Thromboxane-A Synthase; Tissue Plasminogen Activator | 1988 |
Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
Topics: Animals; Blood Pressure; Collagen; Coronary Circulation; Coronary Disease; Dogs; Heart Rate; Imidazoles; Male; Platelet Aggregation; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1986 |
Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion.
Topics: Animals; Blood Pressure; Cats; Coronary Disease; Female; Heart Rate; Imidazoles; Male; Pyridines; Thromboxane B2; Thromboxane-A Synthase; Ventricular Fibrillation | 1986 |